In this issue:
Dose tailoring of anti-TNF-α therapy in CD
Fatigue in newly-diagnosed patients with IBD
Vedolizumab in CD patients failing TNF-antagonist therapy
Gas phase volatile compound biomarker detection
5-ASA dependency in CD
Antibodies and anti-TNF-α levels in IBD
IBD treatment: Do practicing gastroenterologists agree with experts?
Bowel ultrasound in post-operative CD
IBD patients likely to have a prior diagnosis of IBS?
Melanoma and nonmelanoma skin cancer in IBD
Blog: Anti-TNF-α treatment and CD
Please login below to download this issue (PDF)